We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,231
Increased
3,688
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EFTR
7351
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$17.9K ﹤0.01%
+61,667
New +$146K
MXE
7352
Mexico Equity and Income Fund
MXE
$57.9M
$17.9K ﹤0.01%
1,861
+978
+111% +$10.4K
OCSAW
7353
Oculis Holding AG Warrants
OCSAW
$234M
$17.9K ﹤0.01%
+9,652
New +$20K
OGCP
7354
Empire State Realty Series 60
OGCP
$1.34B
$17.8K ﹤0.01%
2,031
+1,520
+297% +$14K
AIOS
7355
AIOS Tech
AIOS
$39.2M
$17.8K ﹤0.01%
255
+200
+364% +$22.3K
OCFT
7356
DELISTED
OneConnect Financial Technology
OCFT
$17.8K ﹤0.01%
11,257
+11,239
+62,439% +$22.5K
OTLK icon
7357
Outlook Therapeutics
OTLK
$193M
$17.8K ﹤0.01%
2,410
-6,913
-74% -$55.5K
UXIN
7358
Uxin Ltd
UXIN
$268M
$17.8K ﹤0.01%
+8,634
New +$19K
BGM
7359
BGM Group Ltd
BGM
$119M
$17.8K ﹤0.01%
5,345
+5,331
+38,079% +$19.4K
PHX
7360
DELISTED
PHX Minerals
PHX
$17.7K ﹤0.01%
5,444
+428
+9% +$1.41K
OFOS
7361
DELISTED
Range Global Offshore Oil Services Index ETF
OFOS
$17.7K ﹤0.01%
+616
New +$17.6K
WMPN
7362
DELISTED
William Penn Bancorporation Common Stock
WMPN
$17.7K ﹤0.01%
1,551
+466
+43% +$5.6K
POET icon
7363
POET Technologies
POET
$1.4B
$17.7K ﹤0.01%
8,533
+1,706
+25% +$3.08K
SDIG
7364
DELISTED
Stronghold Digital Mining, Inc. Class A Common Stock
SDIG
$17.7K ﹤0.01%
4,116
+4,110
+68,500% +$13.8K
CPAC
7365
Cementos Pacasmayo
CPAC
$1.02B
$17.7K ﹤0.01%
3,087
+2,509
+434% +$13.8K
IXHL icon
7366
Incannex Healthcare
IXHL
$36.9M
$17.6K ﹤0.01%
200
+103
+106% +$8.89K
BITI icon
7367
ProShares Short Bitcoin Strategy ETF
BITI
$119M
$17.6K ﹤0.01%
+417
New +$16.4K
DBVT
7368
DBV Technologies
DBVT
$843M
$17.6K ﹤0.01%
+4,402
New +$27K
XWEL icon
7369
XWELL
XWEL
$8.44M
$17.6K ﹤0.01%
9,791
+9,308
+1,927% +$15.9K
FEBW icon
7370
AllianzIM U.S. Equity Buffer20 Feb ETF
FEBW
$199M
$17.5K ﹤0.01%
+592
New +$17.2K
CDTX
7371
DELISTED
Cidara Therapeutics
CDTX
$17.5K ﹤0.01%
1,467
+1,232
+524% +$16.9K
SWKH
7372
DELISTED
SWK Holdings
SWKH
$17.5K ﹤0.01%
1,300
-3,532
-73% -$48.1K
TBN
7373
Tamboran Resources
TBN
$1.12B
$17.5K ﹤0.01%
+777
New +$17.2K
GYLD icon
7374
Arrow Dow Jones Global Yield ETF
GYLD
$37.5M
$17.4K ﹤0.01%
+1,336
New +$17.6K
BWEN icon
7375
Broadwind
BWEN
$106M
$17.3K ﹤0.01%
5,284
-6,382
-55% -$19.1K

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.